Monday, August 5, 2019

Natco Pharma gets EIR from USFDA for Kothur facility

Natco Pharma gets EIR from USFDA for Kothur facility The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company#39;s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2YKWSdz
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...